Maxygen (MAXY) Reports Q1 Loss of $0.03
More News related to MAXY
- Maxygen Reports Third Quarter 2009 Financial Results
- Maxygen (MAXY) Announces Resignation of CEO & CFO
- Maxygen Announces Management Changes
- Maxygen (MAXY) Announces Consummation of Joint Venture Transaction With Astellas
- Maxygen Announces Consummation of Joint Venture Transaction With Astellas
Maxygen, Inc. (Nasdaq: MAXY) reports Q1 loss of $0.03, versus the analyst estimate of ($0.23). Revenue for the quarter was $8.5 million, versus the consensus of $2.33 million.
Related Categories
EarningsStocks Mentioned
-0.17Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
